NZ333229A - - Google Patents

Info

Publication number
NZ333229A
NZ333229A NZ333229A NZ33322997A NZ333229A NZ 333229 A NZ333229 A NZ 333229A NZ 333229 A NZ333229 A NZ 333229A NZ 33322997 A NZ33322997 A NZ 33322997A NZ 333229 A NZ333229 A NZ 333229A
Authority
NZ
New Zealand
Prior art keywords
compound
6alkyl
anxiety
trifluoromethyl
depression
Prior art date
Application number
NZ333229A
Other languages
English (en)
Inventor
Steven Mark Bromidge
Ian Thomson Forbes
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NZ333229A publication Critical patent/NZ333229A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NZ333229A 1996-06-20 1997-06-16 NZ333229A (member.php)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9612883.0A GB9612883D0 (en) 1996-06-20 1996-06-20 Novel compounds

Publications (1)

Publication Number Publication Date
NZ333229A true NZ333229A (member.php) 2000-01-28

Family

ID=10795575

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ333229A NZ333229A (member.php) 1996-06-20 1997-06-16

Country Status (33)

Country Link
US (1) US6369060B1 (member.php)
EP (1) EP0912554B1 (member.php)
JP (1) JP2000512306A (member.php)
KR (1) KR20000022045A (member.php)
CN (1) CN1229408A (member.php)
AP (2) AP9801410A0 (member.php)
AR (1) AR008243A1 (member.php)
AT (1) ATE228514T1 (member.php)
AU (1) AU718597B2 (member.php)
BG (1) BG103089A (member.php)
BR (1) BR9709911A (member.php)
CA (1) CA2258240A1 (member.php)
CO (1) CO4890847A1 (member.php)
CZ (1) CZ420598A3 (member.php)
DE (1) DE69717449T2 (member.php)
DZ (1) DZ2250A1 (member.php)
EA (1) EA001780B1 (member.php)
ES (1) ES2187783T3 (member.php)
GB (1) GB9612883D0 (member.php)
HU (1) HUP9903439A3 (member.php)
ID (1) ID19433A (member.php)
IL (1) IL127417A0 (member.php)
MA (1) MA24214A1 (member.php)
NO (1) NO985972D0 (member.php)
NZ (1) NZ333229A (member.php)
OA (1) OA10944A (member.php)
PE (1) PE86698A1 (member.php)
PL (1) PL330796A1 (member.php)
SK (1) SK282706B6 (member.php)
TR (1) TR199802661T2 (member.php)
TW (1) TW382015B (member.php)
WO (1) WO1997048699A1 (member.php)
ZA (1) ZA975415B (member.php)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999043650A2 (en) * 1998-02-25 1999-09-02 Smithkline Beecham Plc Process(es) for the preparation of 6-trifluoromethyl-indoline derivatives
GB0019950D0 (en) * 2000-08-12 2000-09-27 Smithkline Beecham Plc Compounds
JP2005535560A (ja) * 2001-11-28 2005-11-24 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 治療用の化合物
MXPA04008517A (es) * 2002-03-04 2005-08-19 Pharmacia & Upjohn Co Llc Compuestos terapeuticos.
KR101062376B1 (ko) * 2008-04-10 2011-09-06 한국화학연구원 신규 인돌 카르복실산 비스피리딜 카르복사마이드 유도체,이의 제조방법 및 이를 유효성분으로 함유하는 조성물
WO2010083044A1 (en) 2009-01-16 2010-07-22 Massachusetts Institute Of Technology Diagnosis and treatment of autism spectrum disorders
JP2013545792A (ja) 2010-12-17 2013-12-26 グラクソ グループ リミテッド 眼疾患の処置および防止方法
WO2014046544A1 (en) 2012-09-21 2014-03-27 Aapa B.V. Substituted 3-heteroaryloxy-3-(hetero)aryl-propylamines as serotonin transporter and serotonin ht2c receptor modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001333A1 (en) * 1987-08-07 1989-02-23 The Australian National University IMIDAZO[1,2-b]PYRIDAZINES
NZ254785A (en) * 1992-08-20 1995-09-26 Smithkline Beecham Plc Heterocyclically-condensed indoles and medicaments
GB9313913D0 (en) 1993-07-06 1993-08-18 Smithkline Beecham Plc Novel compounds
TR199700749T1 (xx) * 1995-02-02 1998-02-21 Smithkline Beecham P.L.C. 5-HT resept�r antagonisti olarak indole t�revleri.
GB9607219D0 (en) * 1996-04-04 1996-06-12 Smithkline Beecham Plc Novel compounds
GB9615767D0 (en) * 1996-07-26 1996-09-04 Smithkline Beecham Plc Novel treatment

Also Published As

Publication number Publication date
EA199900043A1 (ru) 1999-06-24
BG103089A (en) 1999-09-30
SK282706B6 (sk) 2002-11-06
ID19433A (id) 1998-07-09
EP0912554A1 (en) 1999-05-06
CN1229408A (zh) 1999-09-22
SK175298A3 (en) 1999-05-07
ES2187783T3 (es) 2003-06-16
EP0912554B1 (en) 2002-11-27
AP9801410A0 (en) 1998-12-31
AU3260297A (en) 1998-01-07
NO985972L (no) 1998-12-18
WO1997048699A1 (en) 1997-12-24
HUP9903439A2 (en) 2000-07-28
BR9709911A (pt) 1999-08-10
TR199802661T2 (xx) 1999-03-22
KR20000022045A (ko) 2000-04-25
OA10944A (en) 2003-02-27
EA001780B1 (ru) 2001-08-27
CA2258240A1 (en) 1997-12-24
NO985972D0 (no) 1998-12-18
ZA975415B (en) 1998-12-21
AR008243A1 (es) 1999-12-29
JP2000512306A (ja) 2000-09-19
MA24214A1 (fr) 1997-12-31
IL127417A0 (en) 1999-10-28
CO4890847A1 (es) 2000-02-28
GB9612883D0 (en) 1996-08-21
CZ420598A3 (cs) 1999-06-16
HUP9903439A3 (en) 2002-12-28
PE86698A1 (es) 1999-01-28
DE69717449T2 (de) 2003-10-02
ATE228514T1 (de) 2002-12-15
DE69717449D1 (de) 2003-01-09
DZ2250A1 (fr) 2002-12-18
AU718597B2 (en) 2000-04-20
AP745A (en) 1999-04-28
AP9701037A0 (en) 1997-07-31
TW382015B (en) 2000-02-11
US6369060B1 (en) 2002-04-09
PL330796A1 (en) 1999-06-07

Similar Documents

Publication Publication Date Title
YU29503A (sh) Novi antiholinergici koji se mogu primeniti kao lekovi, kao i postupak za njihovo dobijanje
ATE177099T1 (de) Diazabicyclische neurokinin antagonisten
MY104627A (en) A 1-pyridylimidazole derivative and its production and use.
DE3876813D1 (de) 3(2h)pyridazinon, verfahren zu dessen herstellung und dieses enthaltendes mittel gegen srs-a.
NZ528997A (en) Sulfonamides
NZ333229A (member.php)
HUT48209A (en) Process for producing heterocyclic oxo compounds comprising substituted amino group and having antiallergic and antiinflammatory action
TW360650B (en) Pyridin-2-ylmethyloxy-pyridin-5-ylcarbamoyl-indoline derivatives, a process for the preparation thereof, and a pharmaceutical composition comprising them
ES2152563T3 (es) Procedimiento para preparar derivados de dihidroxipirimidina.
BR0214578A (pt) Compostos azopolicìclicos fundidos com arila
BG102658A (en) Derivatives of condensed 2,3-benzodiazepines and their use as ampa-receptor inhibitors
BG103271A (en) Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means
MX9701569A (es) Pirimidin(tio)onas substituidas.
MXPA02001406A (es) Heterociclilos-2h-cromenos substituidos.
PT1049672E (pt) Derivados de azetidinocarboxamida para o tratamento de disturbios do snc
MXPA03006057A (es) Proceso para preparar (+) trans-4-p-fluorofenil -3 hidroximetil.
ATE58135T1 (de) 1,3-oxathianderivate.
DK0788472T3 (da) Fremgangsmåde til fremstilling af 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalenderivater
IE880306L (en) Pyridopyrroloquinolines and intermediates thereof
PL335545A1 (en) Application of 2,3,4,5-tetrahydro-1h-3-benzazepines in production of a pharmaceutic composition useful in treating sleep disorders
GB9801501D0 (en) Chemical compounds - II
DK1049670T3 (da) Azetidincarboxamidderivater til behandling af CNS-lidelser
NO20012538L (no) Anvendelse av N-substituerte azabicycloalkanderivater for behandling av forstyrrelser i sentralnervesystemet
DK0949250T3 (da) Fremgangsmåde til fremstilling af alpha1L-adrenoceptorantagonister
ATE227718T1 (de) N-aryloxyethyl-indolyl-alkylamine zur behandlung von depressionen